Wemade Co.Ltd (112040)
KOSDAQ · Korea · prices in KRW · close of 20 Oct 2026
Key indicators
| Last close | KRW 14,450.00 |
|---|---|
| 52-week range | 12,570.00 – 34,850.00 |
| Return, 1 month / 3 months | −9.1% / −15.2% |
| Return, 1 year / 3 years | −45.4% / −58.4% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 70.9% |
| Worst drawdown (1 year) | -58.6% |
| Average daily value traded | 3,169.40M KRW |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wemade is a South Korean video game company that develops and publishes online and mobile games. It is known for its Legend of Mir fantasy role-playing game series, which has attracted players across Asia and beyond. The company also works on blockchain-based games and related digital services. Its customers are gamers and game publishers, and it is based in South Korea.
The shares are listed on the KOSDAQ in Korea under the code 112040, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wemade Co.Ltd (112040) trades on the KOSDAQ in Korea. It last closed at KRW 14,450.00 on 20 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 1,198 of 1,831 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 45.4% and over the last three months it fell 15.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -29.6% | ||
| From 52-week high | -57.0% | ||
| Momentum | 30 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.2% | ||
| 6-month return | -29.2% | ||
| 12-month return, skipping the last month | -40.0% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 70.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -58.6% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 3,169.40M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.9% |
|---|---|
| 1 month | −9.1% |
| 3 months | −15.2% |
| 6 months | −29.2% |
| 1 year | −45.4% |
| 3 years | −58.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 15,548.20 / 20,523.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 683.96 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 295.0000 |
| 27 Dec 2023 | KRW 750.0000 |
| 28 Dec 2022 | KRW 750.0000 |
| 29 Dec 2021 | KRW 650.0000 |
| 29 Dec 2020 | KRW 600.0000 |
| 27 Dec 2019 | KRW 600.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.